The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
News
Services
Subscribe
Advertise
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Rights & permissions
Contact us
Author centre
Chang-Hwan Yoon
Showing 1-4 of 4 articles
BioMatrix versus Orsiro biodegradable polymer stents in all-comer patients with coronary artery disease: the multicentre, randomised BIODEGRADE trial
Yoon C,
Choi Y,
Park J,
Kang S,
Kim S,
Suh J,
Cho Y,
Youn T,
Kim M,
Cha K,
Lee S,
Hong B,
Rha S,
Kang W,
Lee J,
Kim S,
Chae I
April 20, 2021 | 10.4244/EIJ-D-20-00185
Multivessel percutaneous coronary intervention in patients with acute myocardial infarction and severe renal dysfunction
Song P,
Hahn J,
Gwon H,
Jeon K,
Yu C,
Rha S,
Yoon C,
Jeong M
December 6, 2019 | 10.4244/EIJ-D-19-00034
Long-term safety of bioresorbable scaffolds: insights from a network meta-analysis including 91 trials
Kang S,
Gogas B,
Jeon K,
Park J-S,
Lee W,
Yoon C,
Suh J,
Hwang S-S,
Youn T,
Chae I,
Kim H
March 20, 2018 | 10.4244/EIJ-D-17-00646
Angiographic outcomes of Orsiro biodegradable polymer sirolimus-eluting stents and Resolute Integrity durable polymer zotarolimus-eluting stents: results of the ORIENT trial
Kang S,
Chung W-Y,
Lee JM,
Park J,
Yoon C,
Suh J,
Cho Y,
Doh J,
Cho J,
Bae J,
Youn T,
Chae I
January 20, 2017 | 10.4244/EIJ-D-16-00179
1
Latest news
NEW ISSUE
ESC/EAPCI Consensus Statement on Renal Denervation; the Future of TMVR; Mini-focus on Interventional Pharmacology...
March 20, 2023
AHEAD OF PRINT
Early changes in cardiac damage after TAVI
FREE ARTICLE - Yaoyao Zhou et al
March 17, 2023
AHEAD OF PRINT
Posterior pericardiotomy for the prevention of atrial fibrillation
FREE ARTICLE - Ahmed AbdelAziz et al
March 16, 2023
AHEAD OF PRINT
One-year outcomes with the Mistral device
FREE ARTICLE - Kerstin Piayda et al
March 13, 2023
AHEAD OF PRINT
Navitor CE mark cohort outcomes
FREE ARTICLE - Lars Sondergaard et al
March 9, 2023
AHEAD OF PRINT
One-year SAPIEN 3U registry results
FREE ARTICLE - Stefano Cannata et al
March 7, 2023
AHEAD OF PRINT
The POT-PUFF sign: an angiographic mark of stent malapposition during proximal optimisation
FREE ARTICLE - Farhang Aminfar et al
March 3, 2023
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke